1) Updates to IRB review fees for industry sponsored clinical trials
Fees have not been updated since 2023. The revised rates better reflect the resources required to support the review and oversight of industry-sponsored clinical research, including the significant institutional responsibilities that remain with UCLA when an external IRB serves as the reviewing IRB.
We anticipate it will take 6-8 weeks for full implementation. Contracts negotiated with the old fee will be honored.
Fees will continue to be assessed as one-time charges. OHRPP does not assess additional IRB review fees for amendments, continuing reviews, or post-approval reports.
- An updated fee of $3,800 will be charged for UCLA IRB review of industry-sponsored clinical trials that meet the following conditions:
- Designed to assess in humans the safety, efficacy, benefits, adverse reactions, and/or other outcomes of drugs, devices, diagnostics, treatments, procedures, medical evaluations, monitoring or prevention measures; and
- Fully supported by an industry sponsor; and
- Meets the University contractual requirements for industry-supported clinical trials.
- An updated fee of $3,200 will be charged for any industry-sponsored clinical trial that utilizes a reliance mechanism for the IRB review and approval.
Additional information, including updated guidance and frequently asked questions, will be available on the OHRPP website prior to the effective date.
- Questions regarding the updated fee structure or its applicability to a specific study may be directed to Kristin Rochford, Senior Director, OHRPP: kristin.rochford@research.ucla.edu
- For questions about budgeting or negotiating the fee with industry sponsors, please contact Tamika Merrick, Director, Clinical Trials Contracts and Strategic Relations: TMerrick@mednet.ucla.edu
2) Amazon Mechanical Turk (MTurk) is closing on September 30th
If your research uses MTurk for recruitment, data collection, or compensation, you will likely need to submit an amendment in BruinIRB to update the following to ensure a smooth transition for your study and current study participants:
- Remove all references to MTurk from all study documents (e.g. protocol, consent forms, recruitment materials)
- If you plan to continue recruitment and data collection, determine the new method of recruitment/data collection and update all study documents to reflect the new procedures
- Describe how you will communicate the closure to current participants and resolve any outstanding compensation. Please note that if MTurk is the only method you have of contacting participants, this will need to be done in advance of September 30th to ensure participants are properly notified. This means the amendment describing the communication should be submitted as soon as possible to allow time for IRB review.
An amendment is not required if you have completed all study activities and resolved any outstanding compensation.
3) OHRPP’s Office Hours:
Register once to join any session:
Upcoming Office Hours:
- September 24, 2026, at 2pm
- October 8, 2026, at 2pm
This message was originally sent via the Human Research News mailing list. If you would like to subscribe to future announcements, please visit ORA and Department News Subscription